Home › Oropharyngeal Cancer › NCT05880797
Multidimensional and Multimodal Profiling of Oropharyngeal Carcinoma
RecruitingObservational study
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Patients diagnosed with oropharyngeal carcinoma or patients with cancer of the unknown primary that is HPV associated, or possibly deemed to be originating from the oropharynx. Exclusion Criteria: * Not willing to sign consent
About the study
The purpose of this study is to better understand the natural history of oropharyngeal carcinoma (OPC), with or without an association with the human papilloma virus (HPV). For this study, the investigators plan to collect blood from OPC patients prior to treatment and at six subsequent time points.
Sponsor: Stanford University · Participants: 1,000 · Started: Jul 7, 2023
Contact the study team
- Nikita Bedi · Phone: (650) 723-5957
Official record on ClinicalTrials.gov — NCT05880797
Locations in the U.S.
| California | Stanford University, Palo Alto |
Conditions
From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.